Your search returned 7 results.

Results
	1.	SANGUINATE (PEGylated Carboxyhemoglobin Bovine): Mechanism of Action and Clinical Update. [electronic resource] by Abuchowski, Abraham Producer: 20170606 In: Artificial organs vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A Phase I study to determine safety, pharmacokinetics, and pharmacodynamics of ANF-RHO™, a novel PEGylated granulocyte colony-stimulating factor, in healthy volunteers. [electronic resource] by Misra, Hemant Berryman, John Jubin, Ronald Abuchowski, Abraham Producer: 20181227 In: Investigational new drugs vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	PEGylated carboxyhemoglobin bovine (SANGUINATE): results of a phase I clinical trial. [electronic resource] by Misra, Hemant Lickliter, Jason Kazo, Friedericke Abuchowski, Abraham Producer: 20150522 In: Artificial organs vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Early treatment of transient focal cerebral ischemia with bovine PEGylated carboxy hemoglobin transfusion. [electronic resource] by Klaus, Judith A Kibler, Kathleen K Abuchowski, Abraham Koehler, Raymond C Producer: 20110411 In: Artificial cells, blood substitutes, and immobilization biotechnology vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Carbon monoxide form of PEGylated hemoglobin protects myocardium against ischemia/reperfusion injury in diabetic and normal mice. [electronic resource] by Ananthakrishnan, Radha Li, Qing O'Shea, Karen M Quadri, Nosirudeen Wang, Lingjie Abuchowski, Abraham Schmidt, Ann Marie Ramasamy, Ravichandran Producer: 20141006 In: Artificial cells, nanomedicine, and biotechnology vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	A Phase Ib open label, randomized, safety study of SANGUINATE™ in patients with sickle cell anemia. [electronic resource] by Misra, Hemant Bainbridge, James Berryman, John Abuchowski, Abraham Galvez, Kenneth Mauricio Uribe, Luis Fernando Hernandez, Angel Luis Sosa, Nestor Rodolfo Publication details: Revista brasileira de hematologia e hemoterapia In: Revista brasileira de hematologia e hemoterapia vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease. [electronic resource] by Abu Jawdeh, Bassam G Woodle, Ervin Steve Leino, Abbie D Brailey, Paul Tremblay, Simon Dorst, Tonya Abdallah, Mouhamad H Govil, Amit Byczkowski, Daniel Misra, Hemant Abuchowski, Abraham Alloway, Rita R Producer: 20190528 In: Clinical transplantation vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)